FindTrial
Sign In

procainamide

DRUG8 trials

Sponsors

University of Washington, University of Utah, National Heart, Lung, and Blood Institute (NHLBI), Hospital Clinic of Barcelona, Vanderbilt University Medical Center

Conditions

ArrhythmiaArrhythmiasAtrial FibrillationBrugada SyndromeCardiac; Dysrhythmia, PostoperativeCardiovascular DiseasesCongenital Heart SurgeryDeath, Sudden, Cardiac

Phase 3

Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)
CompletedNCT00000518
University of UtahArrhythmia, Cardiovascular Diseases, Death, Sudden, Cardiac +4
Start: 1985-07-31End: 1992-12-31Updated: 2016-01-21
Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)
CompletedNCT00000556
National Heart, Lung, and Blood Institute (NHLBI)Arrhythmia, Atrial Fibrillation, Cardiovascular Diseases +1
Start: 1995-03-31End: 2002-09-30Updated: 2016-03-25
Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)
CompletedNCT00000464
University of WashingtonArrhythmia, Cardiovascular Diseases, Heart Arrest +3
Start: 1987-04-30Updated: 2013-07-29

Phase 4

Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias
CompletedNCT00702117
Hospital Clinic of BarcelonaAtrial Fibrillation, Brugada Syndrome, Tachycardia, Ventricular
Start: 2008-06-30End: 2010-01-31Updated: 2010-12-15
Prevention of Post-Operative Cardiac Arrhythmias
NCT04234906
Jeffrey MoakCardiac; Dysrhythmia, Postoperative, Congenital Heart Surgery
Start: 2023-01-31End: 2023-08-31Target: 870Updated: 2022-03-15
RAFF4 Trial: Vernakalant vs. Procainamide for Acute Atrial Fibrillation in the Emergency Department
CompletedNCT04485195
Ottawa Hospital Research InstituteAtrial Fibrillation
Start: 2021-06-17End: 2024-11-06Updated: 2025-04-10

Unknown Phase

ST-segment Elevation as an AF Endophenotype
CompletedNCT01205529
Vanderbilt University Medical CenterAtrial Fibrillation
Start: 2010-11-30End: 2015-06-30Updated: 2018-05-02
Acute Mechanical Response to Anti-arrhythmic Drug Therapy
WithdrawnNCT02575534
Evan Adelstein, MDArrhythmias
Start: 2015-10-31End: 2018-02-27Updated: 2018-06-28

Related Papers

Vernakalant versus procainamide for rapid cardioversion of patients with acute atrial fibrillation (RAFF4): randomised clinical trial.
2025-11-111 citations
Systolic Blood Pressure Visit-to-Visit Variability and Major Adverse Outcomes in Atrial Fibrillation
Hypertension2017-10-0431 citations